@FierceMedDev: The FBI arrested two former ArthoCare execs, charging them with defrauding investors of $400M. Release | Follow @FierceMedDev
@MarkHFierce: Faridabad in India is becoming a huge hub for medical device and equipment manufacturers. More | Follow @MarkHFierce
@DamianFierce: CareFusion's fourth Class I recall of the summer deals with is Alaris infusion pumps. Article | Follow @DamianFierce
> Wright Medical ($WMGI) priced a $260 million cash convertible senior notes offering. Release
> Royal Philips Electronics ($PHG) will become the sole distributor of Corindus Vascular Robotics' CorPath 200 system, a robotic-assisted device to help treat obstructed coronary arteries. Release
> As many as 72% of drug manufacturers maintain a regular companion diagnostics staff, even though many companies heavily rely on outside partners to develop the technology, according to a new study. Release
> Medtronic ($MDT) has obtained a patent for "implantable medical device crosstalk evaluation and mitigation. Item
> Toshiba America Medical Systems gained FDA clearance for a new CT imaging system. Release
> GE Healthcare ($GE) is looking to get a better foothold in the Indian market by catering to the unique needs of the country's patients, the company said, keeping tabs on local product initiatives. Article
Biotech News
@FierceBiotech: From FierceCRO: Researchers bristle at India's proposed trial reforms. Story | Follow @FierceBiotech
@JohnCFierce: Fate Therapeutics raised a bit more than $9M for their stem cell work. Run by biotech vet Bill Rastetter. More | Follow @JohnCFierce
@RyanMFierce: J&J is heading into Phase III with a new RA drug, add on big inflammation biz, not sure what hopes are for this one. More | Follow @RyanMFierce
> Stem cell biotech Fate nails down $9.2M. News
> ImmunoGen rises on hopes for encores to Roche's armed breast cancer drug. Story
> PRA sets up China shop with interest in Asia growing. More
Pharma News
@FiercePharma: Thumbs up from HSBC on India's pharma sector. Dr Reddy's, Sun Pharma, Cipla are its faves--Reuters. More | Follow @FiercePharma
> AZ's Nexium tops Q2 sales ranks, with BMS' Abilify on its heels. Report
> Pfizer, Mylan plan joint attack on Japanese generics market. Story
Vaccines News
> Bavarian Nordic in peril if U.S. nixes smallpox vaccine order. Report
> Labs, NIH zero in on painless vaccine technology. More
> NIAID provides $7.8M in grants for HIV research. Article
> PATH Malaria Vaccine Initiative creates reference lab. Item
> Merck's Varivax slashes U.S. chickenpox cases. Story
Pharma Manufacturing News
> EU inspectors give Alexza plant the approval that FDA denied it. News
> West tapping growth in India, Asia. More
> Forfeiture of 27 ANDAs is a small piece of Ranbaxy penalties. Item